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Abstract
Background -Inflammation associated with neutrophil infiltration is a commonly observed feature of children with cystic fibrosis. Production of the major neutrophil chemotactic cytokine interleukin 8 (IL-8) is potentially of great importance in the pathology of cystic fibrosis. Concentrations of IL-8 in both sputum and bronchoalveolar lavage fluid have been found to be higher in children with cystic fibrosis than in controls. The IL-8 induced chemotactic response and numbers of IL-8 receptors on peripheral neutrophils obtained from children with cystic fibrosis have been compared with a control group of children. Methods -Cells were isolated from 18 patients with cystic fibrosis (aged 4-20 years) and 13 controls (aged 5-12 years) by dextran centrifugation followed by separation on Lymphoprep. Chemotaxis was assayed using multiwell microchemotaxis chambers and 5 pm polycarbonate filters. Filters were fixed and stained with Haema-Gurr for counting. Results were expressed as numbers of neutrophils per high power field (HPF). Results -At the optimum concentration (1 x 10-'mol1l) the number of cells migrating were similar for controls (150 (12)! HPF) and for the cystic fibrosis group (140 (14) /HPF)). At lower concentrations the numbers of neutrophils migrating were lower for the cystic fibrosis group. Scatchard analysis of "2'I-labelled binding revealed lower numbers of receptors on neutrophils from patients with cystic fibrosis (22 000 
PATIENTS
Chemotaxis experiments Eighteen patients with cystic fibrosis (10 males, eight females) of mean age 10 (range [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] years participated in the study. Thirteen normal controls were recruited from the paediatric day surgery units (12 males and one female) of mean age 7 (range 5-12) years. Control subjects were not enrolled if they had any form of respiratory disorder or current bacterial, viral, or parasitic infection.
IL-8 receptor assays
Six patients with cystic fibrosis (two males, four females) of mean age 10 (range 5-12) years and nine controls (eight males, one female) of mean age 12 (range 6-15) years were recruited for this part of the study.
NEUTROPHIL ISOLATION
Heparinised peripheral venous blood was obtained from all subjects, 5 ml for chemotaxis experiments, 10 ml for receptor assays. Whole blood was mixed with Macrodex (6% dextran in normal saline) in the volume ratio 2:1 and allowed to sediment for 45 minutes at room temperature. The leucocyte rich plasma was collected and layered over an equal volume of Lymphoprep. After centrifugation at 450g for 30 minutes at room temperature the mononuclear cell layer was discarded and the granulocyte pellet was harvested from the tube and washed. Erythrocytes were removed by hypotonic lysis using 0-2% sodium chloride for 15 seconds. Isotonicity was restored by adding an equal volume of 1 6% sodium chloride. The cells were then washed twice more with Hanks' balanced salt solution (HBSS) without calcium and magnesium and finally resuspended in HBSS with calcium and magnesium for neutrophil chemotaxis and in ice cold PBS/1 % BSA without calcium and magnesium for receptor assays. The resulting cell suspension contained more than 96% neutrophils with a viability of more than 95% as assessed by trypan blue exclusion.
NEUTROPHIL CHEMOTAXIS
Chemotaxis assays were performed in duplicate using 48-well microchemotaxis chambers (Neuro Probe, Cabin John, Maryland, USA) with 5,um pore size polyvinylpyrrolidone-free polycarbonate membranes.
Twenty five ild of the chemoattractant f-MetLeu-Phe (fMLP) (10--10-'mol/l) or IL-8 (6 x 10-8-10-'0mol/l) diluted in HBSS with calcium and magnesium were placed in the bottom chamber and 50,l of neutrophil suspension (106 cells/ml) were added to the top chamber. The chambers were incubated for one hour at 37°C in a humidified incubator with 5% CO2. After incubation, non-migrated cells on top of the filter were scraped off and the filter was fixed in methanol for 10 seconds. The filter was air dried and migrated cells stained with Haema-Gurr stain. Neutrophils which migrated to the lower side of the filter were counted using a 400 x magnification in five random high power fields. Experiments were performed in duplicate for each variable and the mean determined. The results were expressed as number of neutrophils/high power field.
IL-8 RECEPTOR ASSAYS
Human recombinant IL-8 was iodinated by the chloramine-T method as previously described.'5 lodinated IL-8 was eluted from a 1 ml bed of Sephadex G-15 in PBS/1% BSA, and remaining unbound '25I removed by dialysis overnight against one litre PBS, with one change of buffer, in a small sac of benzoylated dialysis tubing with a molecular weight cut off at 3500 (Sigma Chemicals, UK The mean (SE) number of cells/high power field migrating at this optimum concentration was not significantly different between the cystic fibrosis and control group (140 (14) and 150 (12), respectively). However, at suboptimal concentrations (1 x 10 -9 and 6 x 10-9 mol/l) the number of migrating neutrophils from patients with cystic fibrosis was significantly decreased compared with the control group (p<005). Figure 1B shows the dose-response curves of both the cystic fibrosis and the control group towards fMLP with maximum migration occurring at 10-7mol/l. The number of cells migrated at this optimum concentration was not significantly different between the cystic fibrosis and control group (182 (12) and 182 (16), respectively).
RECEPTOR ASSAYS
The dissociation binding constants (KD) and the numbers of IL-8 receptors on the surface of the neutrophils were determined by Scatchard analysis. Figure 2 shows typical Scatchard analyses for neutrophils obtained from one of the patients with cystic fibrosis. It illustrates the binding of '25I-labelled IL-8 to neutrophils as a function of the radioligand concentration, and it is clear that non-specific binding was less than 5% of the total bound. Curve fitting, assuming the presence of a single class of binding sites, gave mean KD of 12-7 (4-7) x 10 -0mol/l and 19-3 (7 2) x 10 -'mol/l for the cystic fibrosis and control group, respectively. There was no significant difference in the IL-8 receptor affinity between the two groups (fig 3) . On the other hand, the patients with cystic fibrosis had a significantly lower number of IL-8 receptors (22 198 (2884) receptors/cell) than the controls (75 698 (15 637) receptors/cell) (fig 4) . 
Discussion
Chemoattractant-induced desensitisation of cellular responses occurs by several mechanisms including decrease in receptor number or downregulation, modification of G protein or effector function, or depletion of messengers or their precursors. '6 Our experiments have shown that the chemotactic responsiveness of neutrophils from patients with cystic fibrosis compared with normal subjects is significantly decreased with respect to IL-8, but not fMLP. We have also shown that the number and KD of specific IL-8 receptors on neutrophils from normal children is of the same order (75 000/cell with KD 2 x 10-9mol/l) as previously reported -that is, 75 000/cell with KD 4 x 10 9mol/l,'5 and that neutrophils from children with cystic fibrosis express a lower number (22 000/cell) with a single type of high affinity binding which is not significantly different from normal. IL-8 binding to neutrophils rapidly downregulates receptor expression via internalisation of the ligand-receptor complex. '4 Removal of IL-8 from the medium resulted in the rapid reappearance of receptors on the cell surface, and the rapid recycling of IL-8 receptors was therefore proposed to be essential for the chemotactic response of neutrophils. '4 We have previously shown elevated levels of IL-8 (5 x 10 -10) in the serum of patients with cystic fibrosis,5 indicating that neutrophils in the circulation ofpatients with cystic fibrosis are chronically exposed to higher concentrations of this cytokine. We speculate, therefore, that the chemotactic hyporesponsiveness of peripheral neutrophils in patients with cystic fibrosis is due to downregulation of surface receptor expression, without a change to a lower affinity state, as a result of prior exposure to elevated levels of free IL-8 in the circulation.
The previously reported decrease in neutrophil chemotactic responsiveness to LTB4 in cystic fibrosis was similarly proposed to be consistent with a specific decrease of receptormediated response to LTB4, rather than a generalised abnormality in neutrophil function, as a result of exposure to local high concentrations of LTB4 as cells pass through the pulmonary circulation.'3 The greatest difference between cystic fibrosis and normal neutrophil responses was seen at the optimum concentration ofLTB4 (10-8 mol/1).
" In contrast, we observed a significantly reduced response to IL-8 only at suboptimal concentrations. The accuracy and sensitivity of gradient detection is reduced when receptor density is reduced'6; therefore in low attractant concentrations the response of neutrophils from patients with cystic fibrosis is reduced compared with normal. However, at the highest concentration of IL-8 the response of normal and cystic fibrosis neutrophils is not significantly different since detection of steep concentration gradients is independent of the number of receptors, but correlates with the difference in receptor occupancy across the cells as it orientates in the gradient. '6 In view of the steep IL-8 concentration gradient across the lung tissue of patients with cystic fibrosis5 it is unlikely that receptor downregulation by systemic IL-8 will limit neutrophil recruitment into the lung. As in previous studies'3 we measured no difference in chemotactic responsiveness to fMLP, indicating a specific effect of IL-8. Desensitisation to different chemoattractants at moderate concentrations is independent and specific to the chemoattractants. 16 Non-specific desensitisation occurs only at high concentrations of ligandthat is, at serum concentrations of IL-8 higher than we measured in cystic fibrosis.'
In addition to systemic effects, evidence that in situ generated mediators regulate neutrophil function in inflamed tissue has been reported. 7 Neutrophils infiltrating skin pustules in a patient with relapsing bullous staphyloderma were dysfunctional compared with circulating neutrophils when chemotaxis, degranulation, respiratory burst, and LTB, production were measured in response to IL-8 and C5a. It was suggested that the impaired responsiveness to proinflammatory stimuli of neutrophils migrating into pustules was the result of specific deactivation for receptor-dependent stimuli. The responses of circulating neutrophils in this patient were normal, indicating that the peripheral (intraepidermal) location of the disease restricted the pathological events to the skin. Intraepidermal accumulation of neutrophils is also characteristic of psoriasis, and several recent studies indicate a role for IL-8 in the inflammatory cell infiltration in this disease. 80 A study of IL-8 receptors in normal and psoriatic neutrophils found a slightly raised receptor density in psoriatic neutrophils which was proposed to contribute to neutrophil accumulation in psoriatic skin.2' The implication, as for pustulosis, is that IL-8 generated locally influences neutrophil function, and that systemic IL-8 concentrations are not elevated in these conditions. Free IL-8 is undetectable (10-2 mol/l) in normal serum samples where it is complexed with a specific high affinity autoantibody of the IgG class.22 IL-8 binding to blood neutrophils would inhibit the neutrophil response to a chemotactic gradient; however, the auto- antibody prevents the binding of IL-8 to neutrophils after it diffuses into the circulation from the site of production. Following intravenous injection of lipopolysaccharide serum concentrations of free IL-8 have been found to rise to a peak of 500-900 pglml ( -100`' mol/l) within three hours.23 It appears that the rapid response to such a powerful stimulus for IL-8 secretion overwhelms the protective IgG mechanism normally limiting free IL-8 levels. Levels of autoantibody have been shown to adapt to an increase in the circulating load of IL-8 -for example, in rheumatoid arthritis. 24 In cystic fibrosis it appears, however, that either autoantibody levels which are sufficient to limit free IL-8 in normal individuals are ineffective in the presence of sustained release of IL-8 from inflamed lung tissue, or increased levels of autoantibody are induced in patients with cystic fibrosis which are nevertheless unable to neutralise the circulating IL-8 load. We are currently investigating these possibilities. 
